** BioSig Technologies BSGM.O shares down nearly 9%
premarket as medtech firm prices follow-on
** Co sells 2.5 mln shares at $4, 8% discount to stock's
last sale urn:newsml:reuters.com:*:nGNX6fgr9F
** BSGM plans to use net proceeds for continuation of full
commercialization activities related to PURE EP System, its
noise-filtering technology for ECG and intra-cardiac signals
** Laidlaw sole book-runner for offering
** Co has ~32.2 mln shares outstanding and ~27.6 mln of free
float, per Refinitiv data
** Shares gained 21% this week through Thurs close
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 1-332-219-1430))